This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2006
Title: Richard Chesworth: Innovator in Estrogen Receptor Ligands
Introduction
Richard Chesworth is a notable inventor based in Mystic, CT (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that interact with estrogen receptors. With a total of 2 patents, his work has implications for treating various health conditions.
Latest Patents
Chesworth's latest patents include innovative compounds designed for therapeutic applications. One of his patents focuses on "Acyclic amide and sulfonamide ligands for the estrogen receptor." This invention provides estrogen receptor (ER) ligands of a specific structural formula, along with their pharmaceutically acceptable salts, stereoisomers, and prodrugs. The invention also outlines pharmaceutical compositions that utilize these compounds for treating or preventing diseases mediated by the ER. Another significant patent is for "Tetrahydroisoquinoline compounds as estrogen agonists/antagonists." This invention relates to compounds that can be used to treat or prevent obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, and prostatic disease.
Career Highlights
Richard Chesworth is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative research and development in the field of medicinal chemistry. His contributions have been instrumental in advancing therapeutic options for various diseases.
Collaborations
Chesworth has collaborated with notable colleagues, including Kimberly O Cameron and Paul Andrew Dasilva-Jardine. These collaborations have fostered a productive research environment, leading to the development of impactful pharmaceutical innovations.
Conclusion
Richard Chesworth's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and research contributions continue to pave the way for advancements in treatments for critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile